In-silico and in-vivo evaluation of comparative enhanced neurogenic performance by energy drinks
Keywords:
antidepressant, cognition, dopamine, serotonin, in-silicoAbstract
Objective: In the present society, the energy drinks (EDs) are used by general public and mainly by the sports persons. Though the caffeine content of EDs is creating health consequences on excess consumption, the present study targets their health benefits on central nervous system (CNS) focusing antidepressant and cognitive potentiality. The most typically used EDs have been selected for the study such as Red Bull, Monster and Enerzal for the present research. Methodology: The study started with in-silico studies to get information about the neurological receptor binding of the major and common chemical components of the EDs. The antidepressant study of energy drinks was carried out following FST (Forced Swim Test) and TST (Tail suspension test) methods. Their cognition effect was assessed by using Y-maze apparatus. Further, their mechanism of action was evaluated by estimating their effect on brain dopamine and serotonin level. Results: In-silico study revealed the enhanced agonistic binding of the major common components of the EDs to D2 and serotonin receptors. Further their significant (p<0.001) antidepressant property was estimated both in tail suspension and forced swim tests along with significant cognitive property.
Downloads
References
Ahmed MR, Shaikh MA, Ul Haq SHI, Nazir S. Neuroprotective role of chrysin in attenuating loss of dopaminergic neurons and improving motor, learning and memory functions in rats. Int J Health Sci (Qassim). 2018;12(3):35-43. PMID 29896070.
Alasqah I, Mahmud I, East L, Usher K. Patterns of physical activity and dietary habits among adolescents in Saudi Arabia: A systematic review. Int J Health Sci (Qassim). 2021;15(2):39-48. PMID 33708043.
Alsunni AA. Energy drink consumption: beneficial and adverse health effects. Int J Health Sci (Qassim). 2015;9(4):468-74. doi: 10.12816/0031237, PMID 26715927.
Aziz MA, Sarkar KK, Akter MI. Y-maze, elevated plus maze and hole cross tests of Richardia scabra whole plant. Pharmacol Online. 2016;1:66-72.
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K et al. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58(6 No 1):899-907. doi: 10.1107/s0907444902003451, PMID 12037327.
Chatterjee A, Abraham J. A comprehensive study on sports and energy drinks. In: Sports and energy drinks, the science of beverages. Vol. 10; 2019. p. 515-37.
Coleman JA, Green EM, Gouaux E. X-ray structures and mechanism of the human serotonin transporter. Nature. 2016;532(7599):334-9. doi: 10.1038/nature17629, PMID 27049939.
Coleman JA, Navratna V, Antermite D, Yang D, Bull JA, Gouaux E. Chemical and structural investigation of the paroxetine-human serotonin transporter complex. eLife. 2020;9:e56427. doi: 10.7554/eLife.56427, PMID 32618269.
Collier NB, Hardy MA, Millard-Stafford ML, Warren GL. Small beneficial effect of caffeinated energy drink ingestion on strength. J Strength Cond Res. 2016;30(7):1862-70. doi: 10.1519/JSC.0000000000001289, PMID 26670991.
Curran CP, Marczinski CA. Taurine, caffeine, and energy drinks: reviewing the risks to the adolescent brain. Birth Defects Res. 2017;109(20):1640-8. doi: 10.1002/bdr2.1177, PMID 29251842.
Das S, Sasmal D, Basu SP. Evaluation of CNS depressant activity of different plant parts of Nyctanthes arbortristis linn. Indian J Pharm Sci. 2008;70(6):803-6. doi: 10.4103/0250-474X.49129, PMID 21369448.
Feinstein WP, Brylinski M. Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets. J Cheminform. 2015;7(1):18. doi: 10.1186/s13321-015-0067-5, PMID 26082804.
Gilbert RM. Caffeine consumption. Prog Clin Biol Res. 1984;158:185-213. PMID 6396645.
Haskell CF, Kennedy DO, Wesnes KA, Scholey AB. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology. 2005;179(4):813-25. doi: 10.1007/s00213-004-2104-3, PMID 15678363.
Hoffman JR. Caffeine and energy drinks. Strength Cond J. 2010;32(1):15-20. doi: 10.1519/SSC.0b013e3181bdafa0.
Inceday B, Çopur ÖU, Karabacak AÖ. A perspective on consumption of energy drinks. In: Sports and energy drinks. The science of beverages. Vol. 10; 2019. p. 539-65.
Kadali SR, M C D, Rao A S R S, Sri G K. Antidepressant activity of Brahmi in albino mice. J Clin Diagn Res. 2014;8(3):35-7. doi: 10.7860/JCDR/2014/7482.4098, PMID 24783074.
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202-13. doi: 10.1093/nar/gkv951, PMID 26400175.
Kumar PA, Das S, Mohapatra S, Basu SP, Sharma K, Sharma M et al. Molecular modeling, synthesis, and evaluation of 1-(4-methoxybenzofuran-5-yl)-3-phenylpropane-1, 3-dione for its anxiolytic potentiality. J Appl Pharm Sci. 2020;10(08):139-44.
Kuriyama K, Hashimoto T. Interrelationship between taurine and GABA. Adv Exp Med Biol. 1998;442:329-37. doi: 10.1007/978-1-4899-0117-0_41, PMID 9635048.
Leonard BE, Kafoe WF. A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain. Biochem Pharmacol. 1976;25(17):1939-42. doi: 10.1016/0006-2952(76)90046-0, PMID 985530.
Liguori A, Robinson JH. Caffeine antagonism of alcohol-induced driving impairment. Drug Alcohol Depend. 2001;63(2):123-9. doi: 10.1016/s0376-8716(00)00196-4, PMID 11376916.
Mahmood D. Histamine H3 receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical and clinical perspective. Int J Health Sci (Qassim). 2016;10(4):564-75. doi: 10.12816/0048906, PMID 27833522.
Manikkoth S, B D, Sequeira M, Elizabeth Joy A, Rodrigues R. Assessment of brain dopamine levels to evaluate the role of Tylophora indica ethanolic extract on alcohol induced anxiety in Wistar albino rats. J Young Pharm. 2016;8(2):91-5. doi: 10.5530/jyp.2016.2.6.
Masengo L, Sampasa-Kanyinga H, Chaput JP, Hamilton HA, Colman I. Energy drink consumption, psychological distress, and suicidality among middle and high school students. J Affect Disord. 2020;268:102-8. doi: 10.1016/j.jad.2020.03.004, PMID 32157999.
Mokler DJ, Torres OI, Galler JR, Morgane PJ. Stress-induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res. 2007;1148:226-33. doi: 10.1016/j.brainres.2007.02.031, PMID 17368432.
Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17(2):139-70. doi: 10.1016/0165-0173(92)90012-b, PMID 1356551.
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3(1):33. doi: 10.1186/1758-2946-3-33, PMID 21982300.
Papp M, Gruca P, Lason-Tyburkiewicz M, Litwa E, Niemczyk M, Tota-Glowczyk K et al. Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`. Psychopharmacol. 2017;234(17):2571-85. doi: 10.1007/s00213-017-4651-4, PMID 28567697.
Persad LA. LEnergy drinks and the neurophysiological impact of caffeine. Front Neurosci. 2011;5:116. doi: 10.3389/fnins.2011.00116, PMID 22025909.
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comp Chem. 2004;25(13):1605-12. doi: 10.1002/jcc.20084, PMID 15264254.
Raizel R, Coqueiro AY, Bonvini A, Tirapegui J. Sports and energy drinks: aspects to consider. In: Sports and energy drinks. The science of beverages. Vol. 10; 2019. p. 1-37.
Saleem S, Shaukat F, Gul A, Arooj M, Malik A. Potential role of amino acids in pathogenesis of schizophrenia. Int J Health Sci (Qassim). 2017;11(3):63-8. PMID 28936154.
Sankararaman S, Syed W, Medici V, Sferra TJ. Impact of energy drinks on health and well-being. Curr Nutr Rep. 2018;7(3):121-30. doi: 10.1007/s13668-018-0231-4, PMID 29982915.
Schneider MB, Benjamin HJ. Sports drinks and energy drinks for children and adolescents: are they appropriate? Pediatrics. 2011;127(6):1182-9. doi: 10.1542/peds.2011-0965, PMID 21624882.
Singh T, Biswas D, Jayaram B. AADS-An automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors. J Chem Inf Model. 2011;51(10):2515-27. doi: 10.1021/ci200193z, PMID 21877713.
Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002 Sep 1;40(9):1243-55. doi: 10.1016/s0278-6915(02)00096-0, PMID 12204388.
Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363-7. doi: 10.1093/nar/gky473, PMID 29860391.
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function. Efficient Optimization, and multithreading. J Comp Chem. 2010;31(2):455-61. doi: 10.1002/jcc.21334, PMID 19499576.
Wesołowska A, Kowalska M. Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep. 2008;60(4):464-74. PMID 18799814.
Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell. 2021;184(4):931-942.e18. doi: 10.1016/j.cell.2021.01.027, PMID 33571431.
Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell. 2021;184(4):931-942.e18. doi: 10.1016/j.cell.2021.01.027, PMID 33571431.
Gandamayu, I. B. M., Antari, N. W. S., & Strisanti, I. A. S. (2022). The level of community compliance in implementing health protocols to prevent the spread of COVID-19. International Journal of Health & Medical Sciences, 5(2), 177-182. https://doi.org/10.21744/ijhms.v5n2.1897
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
